Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Antagonizing inhibition gets NK cells going.

Rajagopalan S, Long EO.

Proc Natl Acad Sci U S A. 2010 Jun 8;107(23):10333-4. doi: 10.1073/pnas.1005636107. Epub 2010 Jun 2. No abstract available.

2.

[Natural killer cells and cancer. Regulation by the killer cell Ig-like receptors (KIR)].

Purdy AK, Campbell KS.

Zhongguo Fei Ai Za Zhi. 2010 Jul;13(7):731-6. doi: 10.3779/j.issn.1009-3419.2010.07.14. Review. Chinese. No abstract available.

3.

HLA and KIR polymorphisms affect NK-cell anti-tumor activity.

Passweg JR, Huard B, Tiercy JM, Roosnek E.

Trends Immunol. 2007 Oct;28(10):437-41. Epub 2007 Sep 7.

PMID:
17825623
4.

B-lymphoma cells escape rituximab-triggered elimination by NK cells through increased HLA class I expression.

Borgerding A, Hasenkamp J, Engelke M, Burkhart N, Trümper L, Wienands J, Glass B.

Exp Hematol. 2010 Mar;38(3):213-21. doi: 10.1016/j.exphem.2009.12.007. Epub 2010 Jan 6.

PMID:
20056126
5.

Signal transduction by human NK cell MHC-recognizing receptors.

Binstadt BA, Brumbaugh KM, Leibson PJ.

Immunol Rev. 1997 Feb;155:197-203. Review.

PMID:
9059895
6.

Self-tolerance of human natural killer cells lacking self-HLA-specific inhibitory receptors.

Hasenkamp J, Borgerding A, Uhrberg M, Falk C, Chapuy B, Wulf G, Jung W, Trümper L, Glass B.

Scand J Immunol. 2008 Mar;67(3):218-29. doi: 10.1111/j.1365-3083.2007.02058.x. Epub 2008 Jan 22.

7.

NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.

Björklund AT, Schaffer M, Fauriat C, Ringdén O, Remberger M, Hammarstedt C, Barrett AJ, Ljungman P, Ljunggren HG, Malmberg KJ.

Blood. 2010 Apr 1;115(13):2686-94. doi: 10.1182/blood-2009-07-229740. Epub 2010 Jan 22.

8.

Susceptibility of human melanoma cells to autologous natural killer (NK) cell killing: HLA-related effector mechanisms and role of unlicensed NK cells.

Carrega P, Pezzino G, Queirolo P, Bonaccorsi I, Falco M, Vita G, Pende D, Misefari A, Moretta A, Mingari MC, Moretta L, Ferlazzo G.

PLoS One. 2009 Dec 4;4(12):e8132. doi: 10.1371/journal.pone.0008132.

9.

Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotype.

Hurton LV, Siddik RI, Singh H, Olivares S, Rabinovich BA, Tian R, Mojsilovic D, Hildebrand W, Lee DA, Kelly SS, Champlin R, Shpall EJ, Fernandez-Viña M, Cooper LJ.

Leukemia. 2010 May;24(5):1059-62. doi: 10.1038/leu.2010.19. Epub 2010 Feb 18. No abstract available.

10.

Overview of the killer cell immunoglobulin-like receptor system.

Rajalingam R.

Methods Mol Biol. 2012;882:391-414. doi: 10.1007/978-1-61779-842-9_23. Review.

PMID:
22665247
11.

Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK-cell functions.

Morvan M, David G, Sébille V, Perrin A, Gagne K, Willem C, Kerdudou N, Denis L, Clémenceau B, Folléa G, Bignon JD, Retière C.

Eur J Immunol. 2008 Dec;38(12):3474-86. doi: 10.1002/eji.200838407. Erratum in: Eur J Immunol. 2009 Jan;39(1):324.

12.

Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation.

Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, Moretta A.

Blood. 2011 Jan 20;117(3):764-71. doi: 10.1182/blood-2010-08-264085. Epub 2010 Oct 1. Review.

13.

Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands.

Yu J, Heller G, Chewning J, Kim S, Yokoyama WM, Hsu KC.

J Immunol. 2007 Nov 1;179(9):5977-89. Erratum in: J Immunol. 2007 Dec 15;179(12):8570.

14.

NK cell education: not an on-off switch but a tunable rheostat.

Brodin P, Kärre K, Höglund P.

Trends Immunol. 2009 Apr;30(4):143-9. doi: 10.1016/j.it.2009.01.006. Epub 2009 Mar 11.

PMID:
19282243
15.

A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells.

Rajagopalan S, Long EO.

J Exp Med. 1999 Apr 5;189(7):1093-100. Erratum in: J Exp Med 2000 Jun 5;191(11):following 2027.

16.
17.

NK cells: a lesson from mismatched hematopoietic transplantation.

Frohn C, Brand JM, Luhm J.

Trends Immunol. 2003 Jan;24(1):8-9; author reply 9-10. No abstract available.

PMID:
12495715
18.

Activating killer cell immunoglobulin-like receptor genes' association with recurrent miscarriage.

Vargas RG, Bompeixe EP, França PP, Marques de Moraes M, da Graça Bicalho M.

Am J Reprod Immunol. 2009 Jul;62(1):34-43. doi: 10.1111/j.1600-0897.2009.00709.x.

PMID:
19527230
19.

The tortoise and the hare: slowly evolving T-cell responses take hastily evolving KIR.

van Bergen J, Koning F.

Immunology. 2010 Nov;131(3):301-9. doi: 10.1111/j.1365-2567.2010.03337.x. Epub 2010 Aug 17. Review.

20.

KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro.

Chewning JH, Gudme CN, Hsu KC, Selvakumar A, Dupont B.

J Immunol. 2007 Jul 15;179(2):854-68.

Supplemental Content

Support Center